TRAVERE THERAPEUTICS, INC.: capex
| Value | {"amount": 668000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2253c3ec-1060-4228-8a53-7b8066380795
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-24-000005Retrieved: 2026-08-19T14:10:39.587013+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/capex/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2253c3ec-1060-4228-8a53-7b8066380795
History
- no predecessors — first report